100 filings
8-K
GNPX
Genprex Inc
9 May 24
Departure of Directors or Certain Officers
8:11am
8-K
GNPX
Genprex Inc
20 Mar 24
Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:25am
8-K
GNPX
Genprex Inc
6 Mar 24
Other Events
9:18am
8-K
GNPX
Genprex Inc
26 Feb 24
Other Events
8:45am
8-K
GNPX
Genprex Inc
5 Feb 24
Departure of Directors or Certain Officers
8:15am
8-K
9a4ay5 zu3mloq3xx9hv
2 Feb 24
Departure of Directors or Certain Officers
7:30am
8-K
jxwbj7w32 w76b
31 Jan 24
Material Modifications to Rights of Security Holders
9:00am
8-K
aowu lebr8d30
5 Jan 24
Regulation FD Disclosure
4:17pm
8-K
tpcte2n7m rfhp
18 Dec 23
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
39jb4z 8vdd4tjkk9
13 Dec 23
Entry into a Material Definitive Agreement
4:44pm
8-K
a8toceiyv6o
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:44pm
8-K
a8cte6lgc9be
25 Sep 23
Changes in Registrant's Certifying Accountant
4:20pm
8-K
k3vx1yo fr6zld
8 Sep 23
Regulation FD Disclosure
4:20pm
8-K
6nlx5 jup
1 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:17pm
8-K/A
u1o9n33otbw 6qf2x6k4
21 Aug 23
Changes in Registrant's Certifying Accountant
5:13pm
8-K
jqsw9fcl4
19 Jul 23
Genprex Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:06pm
8-K
yuoca6m5cl g5qme
18 Jul 23
Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh
9:06am
8-K
vck6x cmwwqlaj
14 Jul 23
Changes in Registrant's Certifying Accountant
4:32pm
8-K
2kt64xv
27 Jun 23
Submission of Matters to a Vote of Security Holders
4:28pm
8-K
qmqfbi2satavzbl8mvov
26 May 23
Other Events
4:42pm